Exercise program aims to fight diabetes and muscle decline in older adults

NCT ID NCT07398495

Recruiting now Symptom relief Sponsor: yueh chu wu Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 12-week multimodal exercise program—combining supervised training, home exercises, and digital support—can improve muscle function, physical performance, and blood sugar control in adults aged 45 to 85 with both type 2 diabetes and sarcopenia (age-related muscle loss). Researchers will measure changes in muscle strength, walking speed, and HbA1c levels. The goal is to find a practical, non-drug approach to help this population stay stronger and healthier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multimodal Exercise Program
What this could lead to: If it works, this could point toward a simple, drug-free way to help older adults with diabetes maintain muscle strength and better control their blood sugar.
What could go wrong: This is a small, early-stage behavioral study with no blinding or placebo, so results may be modest or not generalizable. Participants must be able to exercise safely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOPENIA TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Locations

Chung Shan Medical University Hospital
RECRUITING

Taichung, Taiwan, 402306, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.